FDA Approves First Non-Scheduled Drug for Cataplexy in Pediatric Narcolepsy Patients
The treatment was previously approved for excessive daytime sleepiness in pediatric patients 6 years of age and older with narcolepsy.
Read More
Author: SR Edit Staff
Resmed Launches Fabric-Wrapped Full Face Mask to Enhance CPAP Comfort
The newly released AirTouch F30i Comfort features a fabric cushion and frame designed to improve therapy adherence for patients with obstructive sleep apnea.
Read More
Masimo SET Pulse Oximetry Accurate Across Skin Tones in ICU Feasibility Study
The INSPIRE trial analysis suggests no clinically significant difference in accuracy between light and dark skin tones among critically ill patients.
Read More
Alkermes Completes Acquisition of Avadel Pharmaceuticals, Adding LUMRYZ to Portfolio
The acquisition accelerates Alkermes’ entry into the sleep medicine market and incorporates the FDA-approved extended-release sodium oxybate treatment for narcolepsy.
Read More
$23.7M Secured to Scale FDA-Cleared Digital Sleep, Anxiety Treatments
Following the establishment of new CMS reimbursement codes for digital mental health treatments, the funding will support the commercial expansion of two prescription products.
Read More